Boston Scientific Corporation (BSX) Financials

BSX Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 ? ?
2023-12-31 35.1 billion 15.6 billion
2023-09-30 34.0 billion 14.9 billion
2023-06-30 33.6 billion 15.1 billion

BSX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 ? ?
2023-12-31 690.0 million 59.0 million
2023-09-30 492.0 million 59.0 million
2023-06-30 452.0 million 60.0 million

BSX Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2024-03-31 ?
2023-12-31 504.0 million
2023-09-30 504.0 million
2023-06-30 270.0 million

BSX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - -
2023-12-31 865.0 million - 395.0 million
2023-09-30 952.0 million 8.4 billion 404.0 million
2023-06-30 426.0 million 8.5 billion 406.0 million

BSX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 1.5 billion
2023-12-31 1.5 billion
2023-09-30 1.5 billion
2023-06-30 1.5 billion

BSX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 - 366.0 million - -
2023-12-31 267.0 million 363.0 million 1.4 billion -
2023-09-30 206.0 million 356.0 million 1.2 billion -
2023-06-30 206.0 million 359.0 million 207.0 million -

BSX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 3.9 billion 1.2 billion
2023-12-31 3.7 billion 1.1 billion
2023-09-30 3.5 billion 1.1 billion
2023-06-30 3.6 billion 1.1 billion

BSX

Price: $72.86

52 week price:
48.35
74.39

Payout Ratio Range:
42.29%
1625.00%

Earnings Per Share: 1.07 USD

P/E Ratio: 61.64

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Volume: 13.0 million

Ebitda: 425.0 million

Market Capitalization: 107.2 billion

Links: